[
  {
    "info": {
      "NCT": "NCT04685135",
      "Protocol_No": "849-012",
      "jit": "Optimal",
      "trial_name": "Mirati Therapeutics 849-012"
    },
    "disease": {
      "summary": "Advanced Metastatic Non Small Cell Lung Cancer",
      "details": [
        {
          "code": "Non-Small Cell Lung Cancer (NSCLC)",
          "selection": "include"
        }
      ]
    },
    "query": {
      "nct": "NCT04685135",
      "title": "Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation",
      "current_status": "Recruiting",
      "status_verif_date": "September 2022",
      "last_update_date": "September 1, 2022",
      "trial_hold_status": "open",
      "sponsor": "Mirati Therapeutics Inc.",
      "brief_summary": "This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.",
      "conditions": "Metastatic Non Small Cell Lung Cancer | Advanced Non Small Cell Lung Cancer",
      "type": "Interventional",
      "phase": "Phase 3",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "MRTX849",
          "drug": "MRTX849",
          "arm_type": "Experimental",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "MRTX849",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Docetaxel",
          "drug": "Docetaxel",
          "arm_type": "Active Comparator",
          "line_of_therapy": "Not available",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Docetaxel",
              "Gene": "KRAS",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "G12C",
              "Selection": "include",
              "Function": "Not available",
              "summary": "KRAS G12C Mutation  "
            }
          ]
        }
      ],
      "docs": "Q:/MCK/MOA/Precision Oncology/JIT Trials/CarisPharmatechStudyList_2022-07-12.pdf",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT04685135\" target=\"_blank\">NCT04685135<\/a>"
    }
  }
]
